Cargando…

Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator

Pediatric patients suffering from ependymoma are usually treated with cranial or craniospinal three‐dimensional (3D) conformal radiotherapy (3DCRT). Intensity‐modulated techniques spare dose to the surrounding tissue, but the risk for second malignancies may be increased due to the increase in low‐d...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez Moret, Judit, Obermeier, Tina, Pohl, Fabian, Loeschel, Rainer, Koelbl, Oliver, Dobler, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123158/
https://www.ncbi.nlm.nih.gov/pubmed/30125453
http://dx.doi.org/10.1002/acm2.12438
_version_ 1783352801784496128
author Alvarez Moret, Judit
Obermeier, Tina
Pohl, Fabian
Loeschel, Rainer
Koelbl, Oliver
Dobler, Barbara
author_facet Alvarez Moret, Judit
Obermeier, Tina
Pohl, Fabian
Loeschel, Rainer
Koelbl, Oliver
Dobler, Barbara
author_sort Alvarez Moret, Judit
collection PubMed
description Pediatric patients suffering from ependymoma are usually treated with cranial or craniospinal three‐dimensional (3D) conformal radiotherapy (3DCRT). Intensity‐modulated techniques spare dose to the surrounding tissue, but the risk for second malignancies may be increased due to the increase in low‐dose volume. The aim of this study is to investigate if the flattening filter free (FFF) mode allows reducing the risk for second malignancies compared to the mode with flattening filter (FF) for intensity‐modulated techniques and to 3DCRT. A reduction of the risk would be advantageous for treating pediatric ependymoma. 3DCRT was compared to intensity‐modulated radiation therapy (IMRT) and volumetric‐modulated arc therapy (VMAT) with and without flattening filter. Dose–volume histograms (DVHs) were compared to evaluate the plan quality and used to calculate the excess absolute risk (EAR) to develop second cancer in the brain. Dose verification was performed with a two‐dimensional (2D) ionization chamber array and the out‐of‐field dose was measured with an ionization chamber to determine the EAR in peripheral organs. Delivery times were measured. Both VMAT and IMRT achieved similar plan quality in terms of dose sparing in the OAR and higher PTV coverage as compared to 3DCRT. Peripheral dose in low‐dose region, which is proportional to the EAR in organs located in this region, for example, gonads, bladder, or bowel, could be significantly reduced using FFF. The lowest peripheral EAR and lowest delivery times were hereby achieved with VMAT(FFF). The EAR calculated based on DVH in the brain could not be reduced using FFF mode. VMAT(FFF) improved the target coverage and homogeneity and kept the dose in the OAR similar compared to 3DCRT. In addition, delivery times were significantly reduced using VMAT(FFF). Therefore, for radiotherapy of ependymoma patients, VMAT(FFF) may be considered advantageous for the combination of Elekta Synergy linac and Oncentra External Beam planning system used in this study.
format Online
Article
Text
id pubmed-6123158
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61231582018-09-10 Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator Alvarez Moret, Judit Obermeier, Tina Pohl, Fabian Loeschel, Rainer Koelbl, Oliver Dobler, Barbara J Appl Clin Med Phys Radiation Oncology Physics Pediatric patients suffering from ependymoma are usually treated with cranial or craniospinal three‐dimensional (3D) conformal radiotherapy (3DCRT). Intensity‐modulated techniques spare dose to the surrounding tissue, but the risk for second malignancies may be increased due to the increase in low‐dose volume. The aim of this study is to investigate if the flattening filter free (FFF) mode allows reducing the risk for second malignancies compared to the mode with flattening filter (FF) for intensity‐modulated techniques and to 3DCRT. A reduction of the risk would be advantageous for treating pediatric ependymoma. 3DCRT was compared to intensity‐modulated radiation therapy (IMRT) and volumetric‐modulated arc therapy (VMAT) with and without flattening filter. Dose–volume histograms (DVHs) were compared to evaluate the plan quality and used to calculate the excess absolute risk (EAR) to develop second cancer in the brain. Dose verification was performed with a two‐dimensional (2D) ionization chamber array and the out‐of‐field dose was measured with an ionization chamber to determine the EAR in peripheral organs. Delivery times were measured. Both VMAT and IMRT achieved similar plan quality in terms of dose sparing in the OAR and higher PTV coverage as compared to 3DCRT. Peripheral dose in low‐dose region, which is proportional to the EAR in organs located in this region, for example, gonads, bladder, or bowel, could be significantly reduced using FFF. The lowest peripheral EAR and lowest delivery times were hereby achieved with VMAT(FFF). The EAR calculated based on DVH in the brain could not be reduced using FFF mode. VMAT(FFF) improved the target coverage and homogeneity and kept the dose in the OAR similar compared to 3DCRT. In addition, delivery times were significantly reduced using VMAT(FFF). Therefore, for radiotherapy of ependymoma patients, VMAT(FFF) may be considered advantageous for the combination of Elekta Synergy linac and Oncentra External Beam planning system used in this study. John Wiley and Sons Inc. 2018-08-19 /pmc/articles/PMC6123158/ /pubmed/30125453 http://dx.doi.org/10.1002/acm2.12438 Text en © 2018 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Alvarez Moret, Judit
Obermeier, Tina
Pohl, Fabian
Loeschel, Rainer
Koelbl, Oliver
Dobler, Barbara
Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
title Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
title_full Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
title_fullStr Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
title_full_unstemmed Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
title_short Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
title_sort second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123158/
https://www.ncbi.nlm.nih.gov/pubmed/30125453
http://dx.doi.org/10.1002/acm2.12438
work_keys_str_mv AT alvarezmoretjudit secondcancerriskafterradiationtherapyofependymomausingtheflatteningfilterfreeirradiationmodeofalinearaccelerator
AT obermeiertina secondcancerriskafterradiationtherapyofependymomausingtheflatteningfilterfreeirradiationmodeofalinearaccelerator
AT pohlfabian secondcancerriskafterradiationtherapyofependymomausingtheflatteningfilterfreeirradiationmodeofalinearaccelerator
AT loeschelrainer secondcancerriskafterradiationtherapyofependymomausingtheflatteningfilterfreeirradiationmodeofalinearaccelerator
AT koelbloliver secondcancerriskafterradiationtherapyofependymomausingtheflatteningfilterfreeirradiationmodeofalinearaccelerator
AT doblerbarbara secondcancerriskafterradiationtherapyofependymomausingtheflatteningfilterfreeirradiationmodeofalinearaccelerator